Jump to content

2,5-Dimethoxy-4-nitroamphetamine

From Wikipedia, the free encyclopedia
(Redirected from DON (drug))
DON
Clinical data
Other namesDON; 2,5-Dimethoxy-4-nitroamphetamine; 4-Nitro-2,5-dimethoxyamphetamine
Routes of
administration
Oral
Drug classSerotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
Identifiers
  • 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H16N2O4
Molar mass240.259 g·mol−1
3D model (JSmol)
Melting point206 to 207 °C (403 to 405 °F) (hydrochloride)
231-232 °C ((R)-isomer)[1]
  • COc1cc(c(cc1CC(C)N)OC)N(=O)=O
  • InChI=1S/C11H16N2O4/c1-7(12)4-8-5-11(17-3)9(13(14)15)6-10(8)16-2/h5-7H,4,12H2,1-3H3 checkY
  • Key:JQJRESSXOVAECC-UHFFFAOYSA-N checkY
  (verify)

2,5-Dimethoxy-4-nitroamphetamine (DON) is a psychedelic drug and amphetamine.[1] It is an analog of DOM and DOB.[1] It is also closely related to 2C-N.[1] The drug is a serotonin 5-HT2 receptor agonist.[2]

Chemistry

[edit]

DON is in a class of compounds commonly known as α-methyl phenethylamines, or amphetamines and the full chemical name is 1-(2,5-dimethoxy-4-nitrophenyl)propan-2-amine. It has a stereocenter.

Effects

[edit]

In his book PiHKAL, Alexander Shulgin lists a dosage of DON as being 3 to 4.5 mg orally with amphetamine-like stimulation lasting 8 to 15 hours.[1]

Dangers

[edit]

The toxicity of DON is not known.

Pharmacology

[edit]

DON acts as a serotonin 5-HT2A and 5-HT2C receptor partial agonist, albeit with far lower potency and efficacy than other DOx drugs.[2]

Legality

[edit]

DON is unscheduled in the United States, but because of its close similarity in structure and effects to DOM and DOB, possession and sale of DON may be subject to prosecution under the Federal Analog Act.[citation needed] DON is listed as a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act after the table of contents of PiHKAL and TiHKAL were added to the schedules.

See also

[edit]

References

[edit]
  1. ^ a b c d e DON Entry in PiHKAL
  2. ^ a b Acuña-Castillo C, Villalobos C, Moya PR, Sáez P, Cassels BK, Huidobro-Toro JP (June 2002). "Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors". Br J Pharmacol. 136 (4): 510–519. doi:10.1038/sj.bjp.0704747. PMC 1573376. PMID 12055129.
[edit]